Who invested in Ordaos Bio

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$338Kraised across 1 round since 2025, from 1 source

Latest round: Venture, $338KApr 2025
Investors: 1

See who backed them

The rounds

Apr 2025
Venture$338K
- IAG Capital Partners
Source recorded

Founders and team

From Ordaos Bio's own website: 21 on the team.

David LongoChief Executive Officer
Matthias DeneckeChief Technology Officer
Steve HaberChief Solutions Architect
Victor BustosVP of Pre-clinical R&D
Alexandru StirbuSenior AI Scientist
Chris Reed-AsakawaSenior Full Stack Developer
Daniel CohenPrincipal Scientist
Houssem ZerradSenior Backend Engineer
Howard ShelburneSenior Full Stack Developer
Ilya DementyevAssociate Scientist
Jasmine ChoiLab Manager I
Jeff LaFrenceSenior Bioprocess Engineer
John JanczyPrincipal Scientist
Jonas SchemmAssociate Scientist
Lahari GorantlaSenior Product Manager
Luke MartinSenior AI Scientist
Max BluestoneSenior AI Lead
Obeyda DjeffalSenior DevOps Engineer

And 3 more on the team.

Everyone who backed them

IAG Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Ordaos Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.